合成生物企业Intrexon完成IPO招股募集1.84亿美元

 
美国合成生物初创企业Intrexon隔夜首日上市，股价飙升55%，报24.7美元。Intrexon研发的生物基因程序可以帮助开发生产新的、改良的医疗保健、食品、新能源和环保等产品。

 

Intrexon Closes IPO Raising $184M

 Intrexon announced after the close of the market on Tuesday the closing of its initial public offering raising $184 million in gross proceeds.

The Germantown, Md.-based synthetic biology firm said it sold about 11.5 million shares of its common stock at $16 per share. About 10 million shares were sold as part of the initial offering, and another 1.5 million shares were sold to the underwriters of the offering as part of their overallotment option.

JP Morgan and Barclays were joint book-running managers on the offering. Griffin Securities and Mizuho Securities were co-managers.

Intrexon went public on Aug. 8.

In morning trading on the New York Stock Exchange, shares of Intrexon were down 6 percent at $27.03